Sodium Hydroxide → 4-(2-chlorophenyl)-2-[5-(trifluoromethyl)-2H-tetrazol-2-yl]methylpyrimidine-5-carboxylic acid

HRID 1958086ノート

反応式

HRID 1958086 の反応式
[Cl:1][C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][C:3]=1[C:8]1[C:13]([C:14]([O:16]CC)=[O:15])=[CH:12][N:11]=[C:10]([CH2:19][N:20]2[N:24]=[N:23][C:22]([C:25]([F:28])([F:27])[F:26])=[N:21]2)[N:9]=1.[OH-].[Na+]>C(O)C>[Cl:1][C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][C:3]=1[C:8]1[C:13]([C:14]([OH:16])=[O:15])=[CH:12][N:11]=[C:10]([CH2:19][N:20]2[N:24]=[N:23][C:22]([C:25]([F:26])([F:27])[F:28])=[N:21]2)[N:9]=1

参加物

4

実験手順

An amount of 1.74 g (4.21 mmol) of ethyl 4-(2-chlorophenyl)-2-{[5-(trifluoromethyl)-2H-tetrazol-2-yl]methyl}pyrimidine-5-carboxylate was dissolved in 12 ml of ethanol and the solution was admixed dropwise at 0° C. with 45% strength aqueous sodium hydroxide solution (5.05 mmol). The reaction was stirred for a further hour and warmed to RT. The ethanol was then removed under reduced pressure and the residue was admixed with ice-water (10 ml). The aqueous phase was extracted with ethyl acetate. The organic phase was discarded. Then the aqueous phase was adjusted to a pH of 3 using hydrochloric acid, and again extracted with ethyl acetate (3×20 ml). The combined organic phases were dried over sodium sulphate.

後処理

  1. customThe ethanol was then removed under reduced pressure
  2. extractionThe aqueous phase was extracted with ethyl acetate
  3. extractionagain extracted with ethyl acetate (3×20 ml)
  4. dry with materialThe combined organic phases were dried over sodium sulphate

出典と根拠

ORDレコード
ord-55ab3ccd554846b2b458bbf2e1a1472c
出典データセット
uspto-grants-2013_04
特許番号
US08410106B2

反応ノート

読み込み中…